ATE518544T1 - Rotbusch-extrakt gegen diabetes - Google Patents

Rotbusch-extrakt gegen diabetes

Info

Publication number
ATE518544T1
ATE518544T1 AT08717608T AT08717608T ATE518544T1 AT E518544 T1 ATE518544 T1 AT E518544T1 AT 08717608 T AT08717608 T AT 08717608T AT 08717608 T AT08717608 T AT 08717608T AT E518544 T1 ATE518544 T1 AT E518544T1
Authority
AT
Austria
Prior art keywords
diabetes
diabetic agent
diabetic
extract against
aspalathin
Prior art date
Application number
AT08717608T
Other languages
English (en)
Inventor
Peter Mose Larsen
Stephen J Fey
Johan Louw
Lizette Joubert
Original Assignee
Zadec Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zadec Aps filed Critical Zadec Aps
Application granted granted Critical
Publication of ATE518544T1 publication Critical patent/ATE518544T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08717608T 2007-03-12 2008-03-11 Rotbusch-extrakt gegen diabetes ATE518544T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89425807P 2007-03-12 2007-03-12
PCT/EP2008/052861 WO2008110551A1 (en) 2007-03-12 2008-03-11 An anti-diabetic extract of rooibos

Publications (1)

Publication Number Publication Date
ATE518544T1 true ATE518544T1 (de) 2011-08-15

Family

ID=39495123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08717608T ATE518544T1 (de) 2007-03-12 2008-03-11 Rotbusch-extrakt gegen diabetes

Country Status (7)

Country Link
US (1) US8877717B2 (de)
EP (2) EP2368560A1 (de)
JP (1) JP2010520913A (de)
CN (1) CN101765433A (de)
AT (1) ATE518544T1 (de)
ES (1) ES2371393T3 (de)
WO (1) WO2008110551A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2053050T3 (da) † 2007-10-23 2011-11-21 Kneipp Werke Kneipp Mittel Zentrale Gmbh & Co Kg Aspalathin-lignende dihydrochalcon og fremgangsmåde til fremstilling
WO2011120576A1 (en) * 2010-03-31 2011-10-06 Zadec Antidiabetic enolic glucoside of phenylpyruvic acid
WO2012045363A1 (en) 2010-10-07 2012-04-12 Zadec Aps Antidiabetic enolic glucoside of phenylpyruvic acid
JP2016026208A (ja) * 2015-10-28 2016-02-12 サズセ アーペーエスＺａｄｅｃ Ａｐｓ フェニルピルビン酸の抗糖尿病エノール型グルコシド
JP6297621B2 (ja) * 2016-06-08 2018-03-20 サズセ アーペーエスＺａｄｅｃ Ａｐｓ フェニルピルビン酸の抗糖尿病エノール型グルコシド
CN107998220B (zh) * 2016-10-31 2020-09-18 亚宝药业集团股份有限公司 一种用于减少食物摄取、延迟饥饿感、控制体重的组合物
JP2018087233A (ja) * 2018-02-21 2018-06-07 サズセ アーペーエスＺａｄｅｃ Ａｐｓ フェニルピルビン酸の抗糖尿病エノール型グルコシド

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062950A (en) 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
DE2719912C3 (de) 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
US4130714A (en) 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS5953920B2 (ja) 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
IE47592B1 (en) 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5745185A (en) 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
JPS5740478A (en) 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
US4791126A (en) 1980-08-22 1988-12-13 Ono Pharmaceutical Co., Ltd. Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients
DE3166093D1 (en) 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
CA1176269A (en) 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US5066659A (en) 1984-10-30 1991-11-19 Pfizer Inc. Spiro-heteroazalones for treatment of diabetic complications
US4634765A (en) 1984-12-18 1987-01-06 Merrell Dow Pharmaceuticals Inc. Homodisaccharide hypoglycemic agents
GB8524663D0 (en) 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
AU602641B2 (en) 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use
DE3769066D1 (de) 1986-08-28 1991-05-08 Sanwa Kagaku Kenkyusho Co Hydantoin-derivate zur behandlung von komplikationen bei diabetes.
US5192772A (en) 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
GB8801037D0 (en) 1988-01-18 1988-02-17 Plessey Co Ltd Improvements relating to fuel supply systems
US5252572A (en) 1988-02-03 1993-10-12 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same
EP0344383A1 (de) 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Alpha-Glucosidase-Inhibitoren
DE3836675A1 (de) 1988-10-28 1990-05-03 Hoechst Ag Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung
US4980357A (en) 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5037831A (en) 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
US5504078A (en) 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
GB9016978D0 (en) 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
US5091418A (en) 1990-09-28 1992-02-25 Bristol-Myers Squibb Company Novel alpha-glucosidase inhibitor, pradimicin Q
US5217877A (en) 1990-09-28 1993-06-08 Bristol-Myers Squibb Company Process for the preparation of α-glucosidase inhibitor, pradimicin Q
JPH06199695A (ja) * 1992-03-06 1994-07-19 Yunie:Kk 糖尿病改善治療剤
JPH05246875A (ja) 1992-03-06 1993-09-24 Ruibosuteii Japan:Kk 糖尿病改善治療剤
JP2724524B2 (ja) 1992-03-06 1998-03-09 株式会社ユニエ 便秘改善・治療剤
US5728704A (en) 1992-09-28 1998-03-17 Pfizer Inc. Substituted pyridmidines for control of diabetic complications
JP3290834B2 (ja) * 1994-11-25 2002-06-10 昌俊 中野 抗ウィルス剤並びにその製造方法
MX9709874A (es) 1995-06-06 1998-03-31 Pfizer N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
DK0832065T3 (da) 1995-06-06 2001-11-19 Pfizer Substituerede N-(indol-2-carbonyl)glycinamider og derivater som glycogenphosphorylaseinhibitorer
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU7445498A (en) 1997-06-25 1999-01-04 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
KR20000019716A (ko) 1998-09-15 2000-04-15 박호군 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물
DE10118695A1 (de) 2001-04-14 2002-10-17 Helmut Eisemann Getränk und Verfahren zur Herstellung eines Getränks
JP2003171305A (ja) * 2001-11-30 2003-06-20 Yunie:Kk 糖尿病改善治療剤
US6572897B1 (en) * 2002-07-03 2003-06-03 Vitacost.Com, Inc. Insulin sensitivity maintenance and blood sugar level maintenance formulation for the prevention and treatment of diabetes
WO2005010220A1 (ja) 2003-07-25 2005-02-03 Nikko Materials Co., Ltd. 高純度ハフニウム材料、同材料からなるターゲット及び薄膜並びに高純度ハフニウムの製造方法
JP2007070263A (ja) * 2005-09-05 2007-03-22 Oriza Yuka Kk 糖尿病予防用組成物
JP5124152B2 (ja) * 2007-03-05 2013-01-23 タマ生化学株式会社 すい臓β細胞インスリン分泌能促進剤および体内組織細胞グルコース取り込み能促進剤
DK2053050T3 (da) 2007-10-23 2011-11-21 Kneipp Werke Kneipp Mittel Zentrale Gmbh & Co Kg Aspalathin-lignende dihydrochalcon og fremgangsmåde til fremstilling

Also Published As

Publication number Publication date
ES2371393T3 (es) 2011-12-30
CN101765433A (zh) 2010-06-30
US20110275579A1 (en) 2011-11-10
EP2120980A1 (de) 2009-11-25
US8877717B2 (en) 2014-11-04
WO2008110551A1 (en) 2008-09-18
EP2368560A1 (de) 2011-09-28
EP2120980B1 (de) 2011-08-03
JP2010520913A (ja) 2010-06-17

Similar Documents

Publication Publication Date Title
ATE518544T1 (de) Rotbusch-extrakt gegen diabetes
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
ATE441333T1 (de) Zusammensetzung enthaltend oligosaccharide als lísliche ballaststoffe zur verwendung gegen muskelschwund
UA102429C2 (ru) Фармацевтическая композиция, которая включает ингибитор sglt-2, ингибитор дпп-iv и другой антидиабетический агент, и ее применение
MX2010001560A (es) Composicion farmaceutica que comprende un inhibidor de sglt2 en combinacion con un inhibidor de dpp-iv.
MY152037A (en) Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative
TN2011000413A1 (en) Sglt-2inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus impaired glucose tolerance or hyperglycemia
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
UA93384C2 (ru) Способ получения стерилизированного порошкообразного панкреатина
WO2007113222A3 (en) Immunogenic composition
WO2007041365A3 (en) 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
WO2008009379A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
NO20071144L (no) Middel for a tilveiebringe substrater basert pa cellulose og/eller stivelse med vannfrastotende og samtidig soppdrepende, antibakterielle, insektfrastotende og algemotvirkende egenskaper
WO2006102610A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007044737A3 (en) Compositions and methods for reducing blood glucose or insulin after a meal and treating or preventing diabetes
WO2007128817A3 (en) Insulin derivative
EP1924293A4 (de) Zusammensetzung und verfahren zur prävention und behandlung von diabetes typ i
WO2006127882A3 (en) Surface treatment compositions comprising saccharide-siloxane copolymers
WO2007137071A3 (en) Compositions of r(+) and s(-) pramipexole and methods of using the same
WO2008043087A3 (en) Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
WO2008047061A3 (fr) Utilisation cosmetique par voie orale et/ou parenterale de la glucosamine eventuellement associee a au moins un compose polyphenol et composition correspondante
WO2009041014A1 (ja) コンベア用除菌性潤滑剤組成物およびその使用方法
WO2007093853A3 (en) Compositions and methods for treatment and prevention of metabolic syndrome and its associated conditions with combinations of flavonoids, liminoids and tocotrienols
MX2008005409A (es) Modulacion de la expresion de deshidrogenasa 1 de 11beta-hidroxiesteroide.
WO2007149875A3 (en) Compositions and methods for treating, preventing and/or reversing type-1 diabetes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties